Concepedia
Statistics
Publications
30
Citations
6.9K
H-Index
21
Active since
1986
Affiliations
Bristol-Myers Squibb (United States)(Current)
University of Pittsburgh
Queen Mary Hospital
Toronto General Hospital
University of Santo Tomas
Anne Cross is an author at Bristol-Myers Squibb (United States) specializing in antiviral therapy, pharmacy, and pharmacotherapy.
Publications per year
1986–2021
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Ting‐Tsung Chang, Robert G. Gish, Robert de Man et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +10
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
Nikolaos A. Patsopoulos, Sergio E. Baranzini, Adam Santaniello et al. · Science · 2019 · 1.4K citations · Full text
Life Sciences, Genetics, Immunology +17
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Ching‐Lung Lai, Daniel Shouval, Anna S. Lok et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
Morris Sherman, Cihan Yurdaydın, Jose D. Sollano et al. · Gastroenterology · 2006 · 414 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +11
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Michael S. Simberkoff, Anne Cross, Mohamed Al‐Ibrahim et al. · New England Journal of Medicine · 1986 · 401 citations
Veterinary Medicine, Immunology, Infectious Diseases +17
1–5 of 30